Literature DB >> 11687509

Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

C Keller1, A Steensberg, H Pilegaard, T Osada, B Saltin, B K Pedersen, P D Neufer.   

Abstract

In humans, the plasma interleukin 6 (IL-6) concentration increases dramatically during low-intensity exercise. Measurements across the working limb indicate that skeletal muscle is the source of IL-6 production. To determine whether energy availability influences the regulation of IL-6 expression during prolonged exercise, six male subjects completed two trials consisting of 180 min of two-legged dynamic knee extensor with either normal or low (~60% of control) pre-exercise muscle glycogen levels. Increases in plasma IL-6 during exercise were significantly higher (P<0.05) in the low-glycogen (16-fold) trial verses the control (10-fold) trial. Transcriptional activation of the IL-6 gene in skeletal muscle was also higher in the low-glycogen trial; it increased by about 40-fold after 90 min of exercise and about 60-fold after 180 min of exercise. Muscle IL-6 mRNA followed a similar but delayed pattern, increasing by more than 100-fold in the low-glycogen trial and by about 30-fold in the control trial. These data demonstrate that exercise activates transcription of the IL-6 gene in working skeletal muscle, a response that is dramatically enhanced when glycogen levels are low. These findings also support the hypothesis that IL-6 may be produced by contracting myofibers when glycogen levels become critically low as a means of signaling the liver to increase glucose production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687509     DOI: 10.1096/fj.01-0507fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  133 in total

Review 1.  Regulation of Energy Metabolism by Bone-Derived Hormones.

Authors:  Paula Mera; Mathieu Ferron; Ioanna Mosialou
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

2.  The effects of carbohydrate intake and muscle glycogen content on self-paced intermittent-sprint exercise despite no knowledge of carbohydrate manipulation.

Authors:  Melissa Skein; Rob Duffield; Bradley T Kelly; Frank E Marino
Journal:  Eur J Appl Physiol       Date:  2011-12-03       Impact factor: 3.078

Review 3.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

4.  Towards creating a superstimulus to normalise glucose metabolism in the prediabetic: a case-study in the feast-famine and activity-rest cycle.

Authors:  Louis Crowe; Brian Caulfield
Journal:  BMJ Case Rep       Date:  2012-03-27

Review 5.  The influence of skeletal muscle on systemic aging and lifespan.

Authors:  Fabio Demontis; Rosanna Piccirillo; Alfred L Goldberg; Norbert Perrimon
Journal:  Aging Cell       Date:  2013-07-17       Impact factor: 9.304

Review 6.  Exercise and metabolic health: beyond skeletal muscle.

Authors:  John P Thyfault; Audrey Bergouignan
Journal:  Diabetologia       Date:  2020-06-11       Impact factor: 10.122

7.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

8.  Physiology of Mechanotransduction: How Do Muscle and Bone "Talk" to One Another?

Authors:  Janalee Isaacson; Marco Brotto
Journal:  Clin Rev Bone Miner Metab       Date:  2014-06

9.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 10.  Muscle-derived interleukin-6: possible biological effects.

Authors:  B K Pedersen; A Steensberg; P Schjerling
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.